1001077-13-9 Suppliers

Recommended suppliersmore

Product
FOB Price
Min.Order
Supply Ability
Supplier
Contact Supplier

N-(2-((4-Bromopyridin-2-yl)oxy)ethyl)acetamide
Cas No: 1001077-13-9
No Data
No Data
No Data
ENAO Chemical Co, Limited
Contact Supplier

N-(2-(4-broMopyridin-2-yloxy)ethyl)acetaMide
Cas No: 1001077-13-9
No Data
No Data
No Data
Chemical Technology Co.,LTD
Contact Supplier

N-(2-(4-bromopyridin-2-yloxy)ethyl)acetamide
Cas No: 1001077-13-9
No Data
No Data
No Data
Alchemist-pharm chemical Technology Co. Ltd.
Contact Supplier

1001077-13-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1001077-13-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,1,0,7 and 7 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1001077-13:
(9*1)+(8*0)+(7*0)+(6*1)+(5*0)+(4*7)+(3*7)+(2*1)+(1*3)=69
69 % 10 = 9
So 1001077-13-9 is a valid CAS Registry Number.

1001077-13-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name	N-[2-(4-bromopyridin-2-yl)oxyethyl]acetamide

1.2 Other means of identification

Product number	-
Other names	N-(2-(4-bromopyridin-2-yloxy)ethyl)acetamide

1.3 Recommended use of the chemical and restrictions on use

Identified uses	For industry use only.
Uses advised against	no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number	-
Service hours	Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1001077-13-9 SDS

1001077-13-9Upstream product

1001077-13-9Downstream Products

1001077-13-9Relevant articles and documents

BENZIMIDAZOLE CANNABINOID AGONISTS BEARING A SUBSTITUTED HETEROCYCLIC GROUP

-

Paragraph 0276; 0277, (2014/01/07)

The present invention is related to novel benzimidazole compounds of formula (I) having cannabinoid receptor agonistic properties, pharmaceutical compositions comprising these compounds, chemical processes for preparing these compounds and their use in the treatment of diseases linked to the mediation of the cannabinoid receptors in animals, in particular humans.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1001077-13-9

CAS

1001077-13-9